|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005823,
umls-concept:C0008976,
umls-concept:C0023821,
umls-concept:C0035647,
umls-concept:C0038454,
umls-concept:C0041004,
umls-concept:C0199176,
umls-concept:C0201950,
umls-concept:C0301630,
umls-concept:C0428466,
umls-concept:C0441471,
umls-concept:C0580822,
umls-concept:C1442488,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594,
umls-concept:C1801960
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-5-25
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To explore the relative contributions of baseline systolic blood pressure (SBP) and diastolic blood pressure (DBP) and lipoproteins on the risk of recurrent stroke or first major cardiovascular event (MCVE) and their potential impact on the benefit of statin treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1879-1484
|
|
pubmed:author |
pubmed-author:AmarencoPierreP,
pubmed-author:CallahanAlfredA3rd,
pubmed-author:GoldsteinLarry BLB,
pubmed-author:HennericiMichael GMG,
pubmed-author:O'NeillBlair JBJ,
pubmed-author:RudolphAmy EAE,
pubmed-author:SPARCL Investigators,
pubmed-author:SillesenHenrikH,
pubmed-author:SimunovicLisaL,
pubmed-author:WelchK M AKM,
pubmed-author:ZivinJustin AJA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
204
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
515-20
|
|
pubmed:meshHeading |
pubmed-meshheading:18962621-Aged,
pubmed-meshheading:18962621-Blood Pressure,
pubmed-meshheading:18962621-Cardiovascular Diseases,
pubmed-meshheading:18962621-Cholesterol, HDL,
pubmed-meshheading:18962621-Cholesterol, LDL,
pubmed-meshheading:18962621-Female,
pubmed-meshheading:18962621-Heptanoic Acids,
pubmed-meshheading:18962621-Humans,
pubmed-meshheading:18962621-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:18962621-Ischemic Attack, Transient,
pubmed-meshheading:18962621-Male,
pubmed-meshheading:18962621-Middle Aged,
pubmed-meshheading:18962621-Proportional Hazards Models,
pubmed-meshheading:18962621-Pyrroles,
pubmed-meshheading:18962621-Recurrence,
pubmed-meshheading:18962621-Risk Assessment,
pubmed-meshheading:18962621-Risk Factors,
pubmed-meshheading:18962621-Stroke,
pubmed-meshheading:18962621-Time Factors,
pubmed-meshheading:18962621-Treatment Outcome,
pubmed-meshheading:18962621-Triglycerides
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
|
|
pubmed:affiliation |
INSERM U-698 and Denis Diderot University, Paris, France. pierre.amarenco@bch.aphp.fr
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
